The Krey Lab operates at the intersection of Biochemistry, Structural Biology, and Immunology. One of the group's primary research interests is the design and optimization of efficient next-generation vaccines against major human pathogens, including hepatitis C virus (HCV), hepatitis E virus (HEV), human cytomegalovirus (HCMV), and other pathogenic viruses.
This research is part of the human medicine-centered Life Sciences (STEM) of the University of Lübeck in the area of infection biology. The lab bridges fundamental biochemical research (protein folding, structure and stability, protein-protein interactions, and the biochemistry of immune responses) with translational medicine (vaccine development), thereby contributing to the University of Lübeck’s goal of advancing personalized, highly effective therapeutic interventions.